Display options
Cite
Flemming J, Marczenke M, Rudolph IM, et al. Corrigendum to Flemming J, Marczenke M, Rudolph I-M, et al. Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome. Kidney Int. 2020;98:159-167. Kidney Int. 2021;100(2):482doi: 10.1016/j.kint.2021.06.014.
Flemming, J., Marczenke, M., Rudolph, I. M., Nielsen, R., Storm, T., Ilsoe Christensen, E., Diecke, S., Emma, F., & Willnow, T. E. (2021). Corrigendum to Flemming J, Marczenke M, Rudolph I-M, et al. Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome. Kidney Int. 2020;98:159-167. Kidney international, 100(2), 482. https://doi.org/10.1016/j.kint.2021.06.014
Flemming, Julia, et al. "Corrigendum to Flemming J, Marczenke M, Rudolph I-M, et al. Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome. Kidney Int. 2020;98:159-167." Kidney international vol. 100,2 (2021): 482. doi: https://doi.org/10.1016/j.kint.2021.06.014
Flemming J, Marczenke M, Rudolph IM, Nielsen R, Storm T, Ilsoe Christensen E, Diecke S, Emma F, Willnow TE. Corrigendum to Flemming J, Marczenke M, Rudolph I-M, et al. Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome. Kidney Int. 2020;98:159-167. Kidney Int. 2021 Aug;100(2):482. doi: 10.1016/j.kint.2021.06.014. PMID: 34294211; PMCID: PMC8323658.
Copy Download .nbib Format: NLM
Share it on

Kidney Int. 2021 Aug;100(2):482. doi: 10.1016/j.kint.2021.06.014.

Corrigendum to Flemming J, Marczenke M, Rudolph I-M, et al. Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome. Kidney Int. 2020;98:159-167.

Kidney international

Julia Flemming, Maike Marczenke, Ina-Maria Rudolph, Rikke Nielsen, Tina Storm, Erik Ilsoe Christensen, Sebastian Diecke, Francesco Emma, Thomas E Willnow

Affiliations

  1. Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.
  2. Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany; Department of Biology, Chemistry and Pharmacy, Freie Universitaet Berlin, Berlin, Germany.
  3. Department of Biomedicine, Faculty of Health Science, Aarhus University, Aarhus C, Denmark.
  4. Division of Nephrology, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital - IRCCS, Rome, Italy.
  5. Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany; Department of Biomedicine, Faculty of Health Science, Aarhus University, Aarhus C, Denmark.

PMID: 34294211 PMCID: PMC8323658 DOI: 10.1016/j.kint.2021.06.014

[No abstract available.]

Publication Types